Unexplained weight loss (UWL), defined as a loss of 5% of total body weight within a six-month period without a known cause, poses a diagnostic challenge in clinical practice. It can indicate underlying serious illnesses, and thus, necessitates a thorough evaluation.
The initial assessment for UWL should include a detailed history and physical examination. The history should focus on dietary intake, physical activity, psychiatric status, and associated symptoms. The physical examination should be comprehensive, including a thorough examination of the gastrointestinal system, lymph nodes, and thyroid gland.
A stepwise diagnostic approach is recommended for UWL. Initial laboratory tests should include a complete blood count, metabolic panel, thyroid function tests, and urinalysis. If these tests are inconclusive, further investigations such as imaging studies or endoscopies may be warranted. The choice of further tests should be guided by the patient's history and physical examination findings.
Imaging studies play a crucial role in the evaluation of UWL. Computed tomography (CT) of the abdomen and pelvis can identify malignancies, while positron emission tomography (PET) can detect metabolically active diseases. However, these should only be pursued if initial tests are inconclusive and the patient has suggestive symptoms.
Management of UWL depends on the underlying cause. For patients with malignancies or chronic infections, appropriate treatment should be initiated promptly. For patients with psychiatric disorders or malnutrition, a multidisciplinary approach involving psychiatrists and dietitians may be beneficial.
Evaluating unexplained weight loss requires a systematic approach, starting with a thorough history and physical examination, followed by a stepwise diagnostic process. This comprehensive approach can help clinicians identify serious underlying conditions and initiate appropriate management.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation